PET/CT imaging in the diagnosis, staging, and follow-up of colorectal cancer

od Vikram, Raghu, Iyer, Revathy B.
Izdano 2008

Use of computed tomography in the management of colorectal cancer

od Tan, Cher Heng, Iyer, Revathy
Izdano 2010

PET/CT and cross sectional imaging of gynecologic malignancy

od Iyer, Revathy B., Balachandran, Aparna, Devine, Catherine E.
Izdano 2007

PET/CT and hepatic radiation injury in esophageal cancer patients

od Iyer, Revathy B., Balachandran, Aparna, Bruzzi, John F., Johnson, Valen, Macapinlac, Homer A., Munden, Reginald F.
Izdano 2007

Survival Outcomes for Patients with Stage IVB Vulvar Cancer with Grossly Positive Pelvic Lymph Nodes: Time to Reconsider the FIGO Staging System?

od Thaker, Nikhil G., Klopp, Ann H., Jhingran, Anuja, Frumovitz, Michael, Iyer, Revathy B., Eifel, Patricia J.
Izdano u Gynecol Oncol (2014)

Feasibility of a reduced field-of-view diffusion-weighted (rFOV) sequence in assessment of myometrial invasion in patients with clinical FIGO stage I endometrial cancer

od Bhosale, Priya, Ma, Jingfei, Iyer, Revathy, Ramalingam, Preetha, Wei, Wei, Soliman, Pamela, Frumovitz, Michael, Kundra, Vikas
Izdano u J Magn Reson Imaging (2015)

FDG-PET assessment of cervical cancer

od Viswanathan, Chitra, Faria, Silvana, Devine, Catherine, Patnana, Madhavi, Sagebiel, Tara, Iyer, Revathy B., Bhosale, Priya R.
Izdano u PET Clin (2018)

Characteristics and outcomes of patients with recurrent ovarian cancer undergoing early phase immune checkpoint inhibitor clinical trials

od Hinchcliff, Emily, Hong, David, Le, Hung, Chisholm, Gary, Iyer, Revathy, Naing, Aung, Hwu, Patrick, Jazaeri, Amir
Izdano u Gynecol Oncol (2018)

Increase in Post Therapy Tumor Calcification on CT scan is Not an Indicator of Response to Therapy in Low Grade Serous Ovarian Cancer

od Ganeshan, Dhakshinamoorthy, Bhosale, Priya, Wei, Wei, Ramalingam, Preetha, Mudasiru-Dawodu, Eniola, Gershenson, David, Sun, Charlotte, Iyer, Revathy
Izdano u Abdom Radiol (NY) (2016)

The limited utility of magnetic resonance imaging in determining the primary site of disease in patients with inconclusive endometrial biopsy

od Ramirez, Pedro T., Frumovitz, Michael, Milam, Michael R., Deavers, Michael, dos Reis, Ricardo, Iyer, Revathy B., Bhosale, Priya, Schmeler, Kathleen M.
Izdano u Int J Gynecol Cancer (2010)

Hormonal therapy for recurrent low-grade serous carcinoma of the ovary or peritoneum

od Gershenson, David M., Sun, Charlotte C., Iyer, Revathy B., Malpica, Anais L., Kavanagh, John J., Bodurka, Diane C., Schmeler, Kathleen, Deavers, Michael
Izdano u Gynecol Oncol (2012)

Anatomic Distribution of FDG-Avid Paraaortic Lymph Nodes in Patients with Cervical Cancer

od Takiar, Vinita, Fontanilla, Hiral P., Eifel, Patricia J., Jhingran, Anuja, Kelly, Patrick, Iyer, Revathy B., Levenback, Charles F., Zhang, Yongbin, Dong, Lei, Klopp, Ann
Izdano u Int J Radiat Oncol Biol Phys (2013)

Pelvic fractures and changes in bone mineral density following radiotherapy for cervical, endometrial and vaginal cancer: A prospective study of 239 women

od Salcedo, Mila P., Sood, Anil K., Jhingran, Anuja, Eifel, Patricia J., Klopp, Ann H., Iyer, Revathy B., Felllman, Bryan M., Jimenez, Camilo, Schmeler, Kathleen M.
Izdano u Cancer (2020)

Pelvic Fractures After Radiotherapy for Cervical Cancer: Implications for Survivors

od Schmeler, Kathleen M., Jhingran, Anuja, Iyer, Revathy B., Sun, Charlotte C., Eifel, Patricia J., Soliman, Pamela T., Ramirez, Pedro T., Frumovitz, Michael, Bodurka, Diane C., Sood, Anil K.
Izdano u Cancer (2010)

Anatomic Distribution of FDG-Avid Lymph Nodes in Patients with Cervical Cancer,

od Fontanilla, Hiral P., Klopp, Ann H., Lindberg, Mary E., Jhingran, Anuja, Kelly, Patrick, Takiar, Vinita, Iyer, Revathy B., Levenback, Charles F., Zhang, Yongbin, Dong, Lei, Eifel, Patricia J.
Izdano u Pract Radiat Oncol (2012)

CONSENSUS GUIDELINES FOR THE DELINEATION OF THE CLINICAL TARGET VOLUME FOR INTENSITY MODULATED PELVIC RADIOTHERAPY IN THE POSTOPERATIVE TREATMENT OF ENDOMETRIAL AND CERVICAL CANCER

od Small, William, Mell, Loren K., Anderson, Penny, Creutzberg, Carien, De Los Santos, Jennifer, Gaffney, David, Jhingran, Anuja, Portelance, Lorraine, Schefter, Tracey, Iyer, Revathy, Varia, Mahesh, Winter, Kathryn, Mundt, Arno J.
Izdano 2007

A phase II study of GM-CSF and rIFN-γ1b plus carboplatin for the treatment of recurrent, platinum-sensitive ovarian, fallopian tube and primary peritoneal cancer

od Schmeler, Kathleen M., Vadhan-Raj, Saroj, Ramirez, Pedro T., Apte, Sachin M., Cohen, Lorenzo, Bassett, Roland L., Iyer, Revathy B., Wolf, Judith K., Levenback, Charles L., Gershenson, David M., Freedman, Ralph S.
Izdano u Gynecol Oncol (2009)

Cytokines, GM-CSF and IFNγ administered by priming and post-chemotherapy cycling in recurrent ovarian cancer patients receiving carboplatin

od Apte, Sachin M, Vadhan-Raj, Saroj, Cohen, Lorenzo, Bassett, Roland L, Gordon, Ilyssa O, Levenback, Charles F, Ramirez, Pedro T, Gallardo, Stacie T, Patenia, Rebecca S, Garcia, Michael E, Iyer, Revathy B, Freedman, Ralph S
Izdano 2006

Phase Ib-IIa study to reverse platinum resistance by the use of a hypomethylating agent azacitidine in platinum-resistant or refractory epithelial ovarian cancer

od Fu, Siqing, Hu, Wei, Iyer, Revathy, Kavanagh, John J., Coleman, Robert L., Levenback, Charles F., Sood, Anil K., Wolf, Judith K., Gershenson, David M., Markman, Maurie, Hennessy, Bryan T., Kurzrock, Razelle, Bast, Robert C.
Izdano 2010

A multicenter assessment of the ability of preoperative computed tomography scan and CA-125 to predict gross residual disease at primary debulking for advanced epithelial ovarian c...

od Suidan, Rudy S., Ramirez, Pedro T., Sarasohn, Debra M., Teitcher, Jerrold B., Iyer, Revathy B., Zhou, Qin, Iasonos, Alexia, Denesopolis, John, Zivanovic, Oliver, Long Roche, Kara C., Sonoda, Yukio, Coleman, Robert L., Abu-Rustum, Nadeem R., Hricak, Hedvig, Chi, Dennis S.
Izdano u Gynecol Oncol (2017)